Induced Pluripotent Stem (iPS) Cell–derived, Chimeric Antigen Receptor (CAR)-expressing T Cells for Immunotherapy

Science-Business eXchange
doi 10.1038/scibx.2013.1014
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer

American Journal of Hematology
Hematology
2019English

CML Hematopoietic Stem Cells Expressing IL-1RAP Can Be Targeted by Chimeric Antigen Receptor (CAR)-engineered T Cells

Cancer Research
Cancer ResearchOncology
2018English

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer

Frontiers in Immunology
AllergyImmunology
2018English

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Induced Pluripotent Stem (iPS) Cell–derived Pancreatic Β-Like Cells for Treating Diabetes

Science-Business eXchange
2010English

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy

JAMA Oncology
Cancer ResearchOncology
2018English

Collaboration of Chimeric Antigen Receptor (CAR)-expressing T Cells and Host T Cells for Optimal Elimination of Established Ovarian Tumors

OncoImmunology
OncologyAllergyImmunology
2013English

Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer

2019English

Chimeric Antigen Receptor T-Cell Immunotherapy for Glioblastoma: Practical Insights for Neurosurgeons

Neurosurgical Focus
MedicineSurgeryNeurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy